Sep 20, 2022 | Covid-19, News
The new bivalent (two-strain) Moderna COVID-19 vaccine booster triggered stronger neutralizing antibody responses against the highly transmissible Omicron variant at 28 days than the previously authorized booster, with no safety concerns, according to the interim... 
Sep 6, 2022 | Covid-19, News
The US Food and Drug Administration has amended the emergency use authorizations (EUAs) of the Moderna COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine to authorize bivalent formulations of the vaccines for use as a single booster dose at least two months... 
Aug 30, 2022 | Covid-19, News
Moderna yesterday announced that it has submitted an application to the Food and Drug Administration (FDA) for emergency use of its bivalent (two-strain) COVID booster vaccine that targets the BA.4/BA.5 Omicron subvariants, following a similar move this week from...
